LUMIZYME
Live / Registered — Registered and renewed (as of 17 Sept 2020)
What this means for you
Registered since 31 Aug 2010. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 31 Aug 2020).
Record
- Serial number
- 77870953
- Registration number
- 3843069
- Mark type
- Stylized text
- Filed
- 12 Nov 2009
- Published for opposition
- 13 Apr 2010
- Registered
- 31 Aug 2010
- Next maintenance due
- 31 Aug 2020
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of lysosomal storage diseases
Owner
- GENZYME CORPORATION, Cambridge, MA, US
- GENZYME CORPORATION, Cambridge, MA, US
- GENZYME CORPORATION, Cambridge, MA, US
Prosecution history
- 17 Sept 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 17 Sept 2020 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 17 Sept 2020 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 14 Sept 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Aug 2020 — TEAS SECTION 8 & 9 RECEIVED
- 08 Jan 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 10 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Aug 2019 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 02 May 2019 — CORRECTION UNDER SECTION 7 - PROCESSED
- 01 May 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Apr 2019 — TEAS SECTION 7 REQUEST RECEIVED
- 12 Apr 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Apr 2019 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 20 Apr 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 20 Apr 2017 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.